Heinrich F. Magometschnigg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Heinrich F. Magometschnigg has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Katja Pinker
Division of Molecular and Structural Preclinical Imaging (PIL), Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
7 shared publications - Pascal Andreas Thomas Baltzer
Department of Biomedical Imaging and Image-guided Treatment, High field Magnetic Resonance Center (HFMRC), Medical University of Vienna, Vienna, Austria
7 shared publications - Thomas H. Helbich
Medical University of Vienna
6 shared publications Hubert Bickel
Division of Molecular and Gender Imaging, Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria
4 shared publicationsGeorgios Karanikas
Medical University of Vienna, Austria
3 shared publications- Michael Weber
Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria
3 shared publications
Latest Publications
- 30 August 2016
- Published by Springer Nature in European Radiology
- Vol. 27 (5) , 1883-1892
Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values
Objectives To investigate the influence of region-of-interest (ROI) placement and different apparent diffusion coefficient (ADC) parameters on ADC values, diagnostic performance, reproducibility and measurement time in breast tumours. Methods In this IRB-approved, retrospective study, 149 histopathologically proven breast tumours (109 malignant, 40 benign) in 147 women (mean age 53.2) were investigated. Three radiologists independently measured minimum, mean and maximum ADC, each using three ROI placement approaches:1 – small 2D-ROI, 2 – large 2D-ROI and 3 – 3D-ROI covering the whole lesion. One reader performed all measurements twice. Median ADC values, diagnostic performance, reproducibility, and measurement time were calculated and compared between all combinations of ROI placement approaches and ADC parameters. Results Median ADC values differed significantly between the ROI placement approaches (p < .001). Minimum ADC showed the best diagnostic performance (AUC .928–.956), followed by mean ADC obtained from 2D ROIs (.926–.94). Minimum and mean ADC showed high intra- (ICC .85–.94) and inter-reader reproducibility (ICC .74–.94). Median measurement time was significantly shorter for the 2D ROIs (p < .001). Conclusions ROI placement significantly influences ADC values measured in breast tumours. Minimum and mean ADC acquired from 2D-ROIs are useful for the differentiation of benign and malignant breast lesions, and are highly reproducible, with rapid measurement. Key Points • Region of interest placement significantly influences apparent diffusion coefficient of breast tumours. • Minimum and mean apparent diffusion coefficient perform best and are reproducible. • 2D regions of interest perform best and provide rapid measurement times.
- 30 August 2016
- Published by Springer Nature in European Radiology
- Vol. 27 (5) , 1883-1892
Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values
Objectives To investigate the influence of region-of-interest (ROI) placement and different apparent diffusion coefficient (ADC) parameters on ADC values, diagnostic performance, reproducibility and measurement time in breast tumours. Methods In this IRB-approved, retrospective study, 149 histopathologically proven breast tumours (109 malignant, 40 benign) in 147 women (mean age 53.2) were investigated. Three radiologists independently measured minimum, mean and maximum ADC, each using three ROI placement approaches:1 – small 2D-ROI, 2 – large 2D-ROI and 3 – 3D-ROI covering the whole lesion. One reader performed all measurements twice. Median ADC values, diagnostic performance, reproducibility, and measurement time were calculated and compared between all combinations of ROI placement approaches and ADC parameters. Results Median ADC values differed significantly between the ROI placement approaches (p < .001). Minimum ADC showed the best diagnostic performance (AUC .928–.956), followed by mean ADC obtained from 2D ROIs (.926–.94). Minimum and mean ADC showed high intra- (ICC .85–.94) and inter-reader reproducibility (ICC .74–.94). Median measurement time was significantly shorter for the 2D ROIs (p < .001). Conclusions ROI placement significantly influences ADC values measured in breast tumours. Minimum and mean ADC acquired from 2D-ROIs are useful for the differentiation of benign and malignant breast lesions, and are highly reproducible, with rapid measurement. Key Points • Region of interest placement significantly influences apparent diffusion coefficient of breast tumours. • Minimum and mean apparent diffusion coefficient perform best and are reproducible. • 2D regions of interest perform best and provide rapid measurement times.
- Open Access
- 26 May 2016
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 57 (10) , 1518-1522
Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI
Purpose: Background parenchymal enhancement (BPE), and the amount of fibroglandular tissue (FGT) assessed with magnetic resonance imaging (MRI) have been implicated as sensitive imaging biomarkers for breast cancer. The purpose of the study was to quantitatively assess the parenchymal uptake (BPU) on 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) of the breast as another valuable imaging biomarker and examine its correlation with BPE, FGT, and age. Methods: There were 129 patients with normal imaging findings in the one breast (BI-RADS 1) included in this IRB-approved study, whose cases were retrospectively analyzed. All patients underwent prone 18F-FDG PET/CT and 3T CE-MRI of the breast. In all patients, Reader 1 assessed BPU quantitatively using maximum standard uptake values. Two readers assessed FGT and BPE of the normal contralateral breast by subjective visual estimation, as recommended by BI-RADS®. Reader 1 re-assessed all cases and repeated BPU measurements. Appropriate statistical tests were used to assess correlations of BPU, BPE, FGT, and age, as well as inter- and intra-reader agreement. Results: BPU on 18F-FDG PET/CT varied between patients. The mean BPU SUVmax values ± SD for patients with minimal BPE were 1.57 ± SD 0.6, for mild BPE 1.93 ± SD 0.6, for moderate BPE 2.42 ± SD 0.5, and for marked BPE 1.45 ± SD 0.3. There were significant (Pmax was 5.6%, indicating a high reproducibility. Inter-reader and intra-reader agreement for BPE and FGT was almost perfect, with a Kappa value of 0.860 and 0.822, respectively. Conclusion: The results of our study demonstrate that BPU varies between patients. BPU is directly correlated with both BPE and FGT on MRI, and BPU measurements are highly reproducible. Patient age showed strong inverse correlation with all three imaging-derived tissue biomarkers. These findings indicate that BPU may serve as a sensitive imaging biomarker for breast cancer prediction, prognosis, and risk assessment.
- 26 May 2016
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 57 (10) , 1518-1522
Open AccessQuantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI
Purpose: Background parenchymal enhancement (BPE), and the amount of fibroglandular tissue (FGT) assessed with magnetic resonance imaging (MRI) have been implicated as sensitive imaging biomarkers for breast cancer. The purpose of the study was to quantitatively assess the parenchymal uptake (BPU) on 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) of the breast as another valuable imaging biomarker and examine its correlation with BPE, FGT, and age. Methods: There were 129 patients with normal imaging findings in the one breast (BI-RADS 1) included in this IRB-approved study, whose cases were retrospectively analyzed. All patients underwent prone 18F-FDG PET/CT and 3T CE-MRI of the breast. In all patients, Reader 1 assessed BPU quantitatively using maximum standard uptake values. Two readers assessed FGT and BPE of the normal contralateral breast by subjective visual estimation, as recommended by BI-RADS®. Reader 1 re-assessed all cases and repeated BPU measurements. Appropriate statistical tests were used to assess correlations of BPU, BPE, FGT, and age, as well as inter- and intra-reader agreement. Results: BPU on 18F-FDG PET/CT varied between patients. The mean BPU SUVmax values ± SD for patients with minimal BPE were 1.57 ± SD 0.6, for mild BPE 1.93 ± SD 0.6, for moderate BPE 2.42 ± SD 0.5, and for marked BPE 1.45 ± SD 0.3. There were significant (Pmax was 5.6%, indicating a high reproducibility. Inter-reader and intra-reader agreement for BPE and FGT was almost perfect, with a Kappa value of 0.860 and 0.822, respectively. Conclusion: The results of our study demonstrate that BPU varies between patients. BPU is directly correlated with both BPE and FGT on MRI, and BPU measurements are highly reproducible. Patient age showed strong inverse correlation with all three imaging-derived tissue biomarkers. These findings indicate that BPU may serve as a sensitive imaging biomarker for breast cancer prediction, prognosis, and risk assessment.
- 7 April 2016
- Published by Wiley in NMR in Biomedicine
- Vol. 29 (6) , 702-708
Influence of fat-water separation and spatial resolution on automated volumetric MRI measurements of fibroglandular breast tissue
- 7 April 2016
- Published by Wiley in NMR in Biomedicine
- Vol. 29 (6) , 702-708
Influence of fat-water separation and spatial resolution on automated volumetric MRI measurements of fibroglandular breast tissue
- 30 June 2015
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 42 (11) , 1656-1665
Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T
To compare the diagnostic accuracy of prone (18)F-FDG PET/CT with that of contrast-enhanced MRI (CE-MRI) at 3 T in suspicious breast lesions. To evaluate the influence of tumour size on diagnostic accuracy and the use of maximum standardized uptake value (SUVMAX) thresholds to differentiate malignant from benign breast lesions. A total of 172 consecutive patients with an imaging abnormality were included in this IRB-approved prospective study. All patients underwent (18)F-FDG PET/CT and CE-MRI of the breast at 3 T in the prone position. Two reader teams independently evaluated the likelihood of malignancy as determined by (18)F-FDG PET/CT and CE-MRI independently. (18)F-FDG PET/CT data were qualitatively evaluated by visual interpretation. Quantitative assessment was performed by calculation of SUVMAX. Sensitivity, specificity, diagnostic accuracy, area under the curve and interreader agreement were calculated for all lesions and for lesions <10 mm. Histopathology was used as the standard of reference. There were 132 malignant and 40 benign lesions; 23 lesions (13.4%) were <10 mm. Both (18)F-FDG PET/CT and CE-MRI achieved an overall diagnostic accuracy of 93%. There were no significant differences in sensitivity (p = 0.125), specificity (p = 0.344) or diagnostic accuracy (p = 1). For lesions <10 mm, diagnostic accuracy deteriorated to 91% with both (18)F-FDG PET/CT and CE-MRI. Although no significant difference was found for lesions <10 mm, CE-MRI at 3 T seemed to be more sensitive but less specific than (18)F-FDG PET/CT. Interreader agreement was excellent (κ = 0.85 and κ = 0.92). SUVMAX threshold was not helpful in differentiating benign from malignant lesions. (18)F-FDG PET/CT and CE-MRI at 3 T showed equal diagnostic accuracies in breast cancer diagnosis. For lesions <10 mm, diagnostic accuracy deteriorated, but was equal for (18)F-FDG PET/CT and CE-MRI at 3 T. For lesions <10 mm, CE-MRI at 3 T seemed to be more sensitive but less specific than (18)F-FDG PET/CT. Quantitative assessment using an SUVMAX threshold for differentiating benign from malignant lesions was not helpful in breast cancer diagnosis.
- 30 June 2015
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 42 (11) , 1656-1665
Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T
To compare the diagnostic accuracy of prone (18)F-FDG PET/CT with that of contrast-enhanced MRI (CE-MRI) at 3 T in suspicious breast lesions. To evaluate the influence of tumour size on diagnostic accuracy and the use of maximum standardized uptake value (SUVMAX) thresholds to differentiate malignant from benign breast lesions. A total of 172 consecutive patients with an imaging abnormality were included in this IRB-approved prospective study. All patients underwent (18)F-FDG PET/CT and CE-MRI of the breast at 3 T in the prone position. Two reader teams independently evaluated the likelihood of malignancy as determined by (18)F-FDG PET/CT and CE-MRI independently. (18)F-FDG PET/CT data were qualitatively evaluated by visual interpretation. Quantitative assessment was performed by calculation of SUVMAX. Sensitivity, specificity, diagnostic accuracy, area under the curve and interreader agreement were calculated for all lesions and for lesions <10 mm. Histopathology was used as the standard of reference. There were 132 malignant and 40 benign lesions; 23 lesions (13.4%) were <10 mm. Both (18)F-FDG PET/CT and CE-MRI achieved an overall diagnostic accuracy of 93%. There were no significant differences in sensitivity (p = 0.125), specificity (p = 0.344) or diagnostic accuracy (p = 1). For lesions <10 mm, diagnostic accuracy deteriorated to 91% with both (18)F-FDG PET/CT and CE-MRI. Although no significant difference was found for lesions <10 mm, CE-MRI at 3 T seemed to be more sensitive but less specific than (18)F-FDG PET/CT. Interreader agreement was excellent (κ = 0.85 and κ = 0.92). SUVMAX threshold was not helpful in differentiating benign from malignant lesions. (18)F-FDG PET/CT and CE-MRI at 3 T showed equal diagnostic accuracies in breast cancer diagnosis. For lesions <10 mm, diagnostic accuracy deteriorated, but was equal for (18)F-FDG PET/CT and CE-MRI at 3 T. For lesions <10 mm, CE-MRI at 3 T seemed to be more sensitive but less specific than (18)F-FDG PET/CT. Quantitative assessment using an SUVMAX threshold for differentiating benign from malignant lesions was not helpful in breast cancer diagnosis.
- 30 June 2014
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (13) , 3540-3549
Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study
Purpose: To assess whether multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging (MRI) (MP 18FDG PET-MRI) using dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), three-dimensional proton MR spectroscopic imaging (3D 1H-MRSI), and 18FDG-PET enables an improved differentiation of benign and malignant breast tumors. Experimental Design: Seventy-six female patients (mean age, 55.7 years; range, 25–86 years) with an imaging abnormality (BI-RADS 0, 4–5) were included in this Institutional Review Board (IRB)-approved study. Patients underwent fused PET-MRI of the breast with 18FDG-PET/CT and MP MRI at 3T. The likelihood of malignancy was assessed for all single parameters, for MP MRI with two/three parameters, and for MP 18FDG PET-MRI. Histopathology was used as the standard of reference. Appropriate statistical tests were used to assess sensitivity, specificity, and diagnostic accuracy for each assessment combination. Results: There were 53 malignant and 23 benign breast lesions. MP 18FDG PET-MRI yielded a significantly higher area under the cure (AUC) of 0.935 than DCE-MRI (AUC, 0.86; P = 0.044) and the combination of DCE-MRI and another parameter (AUC, 0.761–0.826; P = 0.013–0.020). MP 18FDG PET-MRI showed slight further improvement to MP MRI with three parameters (AUC, 0.925; P = 0.317). Using MP 18FDG PET-MRI there would have been a reduction of the unnecessary breast biopsies recommended by MP imaging with one or two parameters (P = 0.002–0.011). Conclusion: This feasibility study shows that MP 18FDG PET-MRI enables an improved differentiation of benign and malignant breast tumors when several MRI and PET parameters are combined. MP 18FDG PET-MRI may lead to a reduction in unnecessary breast biopsies. Clin Cancer Res; 20(13); 3540–9. ©2014 AACR.
- 30 June 2014
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (13) , 3540-3549
Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study
Purpose: To assess whether multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging (MRI) (MP 18FDG PET-MRI) using dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), three-dimensional proton MR spectroscopic imaging (3D 1H-MRSI), and 18FDG-PET enables an improved differentiation of benign and malignant breast tumors. Experimental Design: Seventy-six female patients (mean age, 55.7 years; range, 25–86 years) with an imaging abnormality (BI-RADS 0, 4–5) were included in this Institutional Review Board (IRB)-approved study. Patients underwent fused PET-MRI of the breast with 18FDG-PET/CT and MP MRI at 3T. The likelihood of malignancy was assessed for all single parameters, for MP MRI with two/three parameters, and for MP 18FDG PET-MRI. Histopathology was used as the standard of reference. Appropriate statistical tests were used to assess sensitivity, specificity, and diagnostic accuracy for each assessment combination. Results: There were 53 malignant and 23 benign breast lesions. MP 18FDG PET-MRI yielded a significantly higher area under the cure (AUC) of 0.935 than DCE-MRI (AUC, 0.86; P = 0.044) and the combination of DCE-MRI and another parameter (AUC, 0.761–0.826; P = 0.013–0.020). MP 18FDG PET-MRI showed slight further improvement to MP MRI with three parameters (AUC, 0.925; P = 0.317). Using MP 18FDG PET-MRI there would have been a reduction of the unnecessary breast biopsies recommended by MP imaging with one or two parameters (P = 0.002–0.011). Conclusion: This feasibility study shows that MP 18FDG PET-MRI enables an improved differentiation of benign and malignant breast tumors when several MRI and PET parameters are combined. MP 18FDG PET-MRI may lead to a reduction in unnecessary breast biopsies. Clin Cancer Res; 20(13); 3540–9. ©2014 AACR.
- 22 February 2014
- Published by Springer Nature in Der Radiologe
- Vol. 54 (3) , 241-253
Molekulare Brustbildgebung
- 22 February 2014
- Published by Springer Nature in Der Radiologe
- Vol. 54 (3) , 241-253
Molekulare Brustbildgebung
- 19 February 2014
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 14 (6) , 711-722
Molecular imaging for the characterization of breast tumors
Recently, molecular imaging, using various techniques, has been assessed for breast imaging. Molecular imaging aims to quantify and visualize biological, physiological, and pathological processes at the cellular and molecular levels to further elucidate the development and progression of breast cancer and the response to treatment. Molecular imaging enables the depiction of tumor morphology, as well as the assessment of functional and metabolic processes involved in cancer development at different levels. To date, molecular imaging techniques comprise both nuclear medicine and radiological techniques. This review aims to summarize the current and emerging functional and metabolic techniques for the molecular imaging of breast tumors.
- 19 February 2014
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 14 (6) , 711-722
Molecular imaging for the characterization of breast tumors
Recently, molecular imaging, using various techniques, has been assessed for breast imaging. Molecular imaging aims to quantify and visualize biological, physiological, and pathological processes at the cellular and molecular levels to further elucidate the development and progression of breast cancer and the response to treatment. Molecular imaging enables the depiction of tumor morphology, as well as the assessment of functional and metabolic processes involved in cancer development at different levels. To date, molecular imaging techniques comprise both nuclear medicine and radiological techniques. This review aims to summarize the current and emerging functional and metabolic techniques for the molecular imaging of breast tumors.
- 1 December 1992
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 40 (06) , 356-360
The Use of Mesh-tube-Constricted Dilated or Varicose Veins as Arterial Bypass Conduit
In general, dilated and varicose veins are not used as arterial bypass grafts despite their physiological endothelial lining. A uniform small diameter may be achieved by inserting such veins into mesh tubes. To test the degree to which dilated veins can be constricted without forming folds, in-vitro and experimental investigations were performed before such composites were used for clinical reconstruetive surgery. Ovine jugular veins with a diameter of 15 mm were inserted into 6 mm tubes. After casting in paraffin wax none of the specimens showed folds on the flow surface. In 12 sheep pairs of mesh-constricted jugular veins and native femoral veins wore implanted as femoropopliteal bypass grafts. Six animals were killed at 6 months and 6 at one year. All bypasses remained patent and none showed signs of obstruction caused by folds or anastomotic hyperplasia at angiographic control. Intimal hyperplasia was significantly reduced from 416 ± 143μm in the midportion of native vein grafts to 231 ± 76μm (p = 0.0001 paired t-test) in constricted veins as well as at the anastomoses (358 ± 256 μm vs. 180 ± 73 μm; p = 0.008). Partially or totally mesh-tube-constricted varicose veins wore used for infrainguinal reconstruetions in 19 patients and for coronary revascularization in 3. All grafts showed an even calibration at control angiography. As constriction does not lead to internal folds, varicose or dilated veins may be used sucessfully as bypass grafts after insertion into mesh tubes. The external reinforcement reduces the intimal hyperplasia within the graft and also reduces anastomotic hyperplasia. Dilatierte oder variköse Venen werden, obwohl sie eine physiologische Endothelauskleidung haben, im allgemeinen nicht als Bypasstransplantate verwendet. Durch Einziehen solcher Venen in Schlauchmaterialien kann ein gleichförmiger Querschnitt erzielt werden. Um festzustellen wieweit die Kaliberreduktion möglich ist, ohne daß es zur Faltenbildung der Wand kommt, wurden In-vitro- und experimentelle Untersuchungen durchgeführt, bevor umhüllte Venen klinisch als Gefäßersatz verwendet wurden. Jugularvenen von Schafen mit einem Durchmesser von 15 mm wurden in 6-mm-Netzschläuche eingezogen. Nach dem Ausgießen mit Paraffinwax zeigte keines der Präparate Falten an der inneren Oberfläche. Netzumhüllte Jugularvenen und native Femoralvenen wurden in Paaren bei 12 Schafen als femoropoplitealer Bypass implantiert. Sechs Tiere wurden nach einem halben Jahr und weitere 6 nach 12 Monaten nachuntersucht. Alle Bypasses waren durchgängig und frei von Stenosen. Die Intimahyperplasie war bei den umhüllten Venen signifikant gegenüber den nativ implantierten Venen reduziert (231 ± 76 μm vs 416 ± 143μm; p = 0,0001 gepaarter t-Test). Ebenso war dies im Bereich der Anastomosen festzustellen (180 ± 73 vs 358 ± 256μm; p = 0,008). Komplett oder teilweise netzverstärkte Venen wurden bei 19 Patienten für periphere und bei 3 für aortokoronare Revaskularisationen verwendet. Alle Grafts zeigten einen gleichmäßigen Querschnitt in der Kontrollangiographie. Da eine Kaliberreduktion dilatierter oder variköser Venen durch Einziehen in Netzschläuche nicht zu einer Faltenbildung führt, können solche erfolgreich als Bypasstransplantat verwendet werden. Durch Verstärkung von außen kommt es zu einer Reduktion der Intimadicke im Graft und an den Anastomosen.
- 1 December 1992
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 40 (06) , 356-360
The Use of Mesh-tube-Constricted Dilated or Varicose Veins as Arterial Bypass Conduit
In general, dilated and varicose veins are not used as arterial bypass grafts despite their physiological endothelial lining. A uniform small diameter may be achieved by inserting such veins into mesh tubes. To test the degree to which dilated veins can be constricted without forming folds, in-vitro and experimental investigations were performed before such composites were used for clinical reconstruetive surgery. Ovine jugular veins with a diameter of 15 mm were inserted into 6 mm tubes. After casting in paraffin wax none of the specimens showed folds on the flow surface. In 12 sheep pairs of mesh-constricted jugular veins and native femoral veins wore implanted as femoropopliteal bypass grafts. Six animals were killed at 6 months and 6 at one year. All bypasses remained patent and none showed signs of obstruction caused by folds or anastomotic hyperplasia at angiographic control. Intimal hyperplasia was significantly reduced from 416 ± 143μm in the midportion of native vein grafts to 231 ± 76μm (p = 0.0001 paired t-test) in constricted veins as well as at the anastomoses (358 ± 256 μm vs. 180 ± 73 μm; p = 0.008). Partially or totally mesh-tube-constricted varicose veins wore used for infrainguinal reconstruetions in 19 patients and for coronary revascularization in 3. All grafts showed an even calibration at control angiography. As constriction does not lead to internal folds, varicose or dilated veins may be used sucessfully as bypass grafts after insertion into mesh tubes. The external reinforcement reduces the intimal hyperplasia within the graft and also reduces anastomotic hyperplasia. Dilatierte oder variköse Venen werden, obwohl sie eine physiologische Endothelauskleidung haben, im allgemeinen nicht als Bypasstransplantate verwendet. Durch Einziehen solcher Venen in Schlauchmaterialien kann ein gleichförmiger Querschnitt erzielt werden. Um festzustellen wieweit die Kaliberreduktion möglich ist, ohne daß es zur Faltenbildung der Wand kommt, wurden In-vitro- und experimentelle Untersuchungen durchgeführt, bevor umhüllte Venen klinisch als Gefäßersatz verwendet wurden. Jugularvenen von Schafen mit einem Durchmesser von 15 mm wurden in 6-mm-Netzschläuche eingezogen. Nach dem Ausgießen mit Paraffinwax zeigte keines der Präparate Falten an der inneren Oberfläche. Netzumhüllte Jugularvenen und native Femoralvenen wurden in Paaren bei 12 Schafen als femoropoplitealer Bypass implantiert. Sechs Tiere wurden nach einem halben Jahr und weitere 6 nach 12 Monaten nachuntersucht. Alle Bypasses waren durchgängig und frei von Stenosen. Die Intimahyperplasie war bei den umhüllten Venen signifikant gegenüber den nativ implantierten Venen reduziert (231 ± 76 μm vs 416 ± 143μm; p = 0,0001 gepaarter t-Test). Ebenso war dies im Bereich der Anastomosen festzustellen (180 ± 73 vs 358 ± 256μm; p = 0,008). Komplett oder teilweise netzverstärkte Venen wurden bei 19 Patienten für periphere und bei 3 für aortokoronare Revaskularisationen verwendet. Alle Grafts zeigten einen gleichmäßigen Querschnitt in der Kontrollangiographie. Da eine Kaliberreduktion dilatierter oder variköser Venen durch Einziehen in Netzschläuche nicht zu einer Faltenbildung führt, können solche erfolgreich als Bypasstransplantat verwendet werden. Durch Verstärkung von außen kommt es zu einer Reduktion der Intimadicke im Graft und an den Anastomosen.